Opus Genetics
(NASDAQ) OCUP
Opus Genetics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$4.37M
Net Income (TTM)
$49.59M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
OCUP News
OCUP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Opus Genetics
Industry
Biotechnology
Sector
Health CareEmployees
28
CEO
George Magrath, III, MD
Website
opusgtx.comHeadquarters
Farmington Hills, MI 48335, US
OCUP Financials
Key Financial Metrics (TTM)
Gross Margin
57%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-5%
Return on Capital
-91%
Return on Assets
-99%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$38.60M
EBITDA
$38.60M
Operating Cash Flow
$35.25M
Capital Expenditure
$0.00
Free Cash Flow
$35.25M
Cash & ST Invst.
$45.09M
Total Debt
$0.00
Opus Genetics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.37M
+196.8%
Gross Profit
$4.37M
+115.9%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
14
N/A
Net Income
$16.52M
+53.0%
EBITDA
$2.39M
+93.7%
Quarterly Fundamentals
Net Cash
$45.09M
+48.7%
Accounts Receivable
$3.17M
-45.2%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-98.70%
N/A
Return on Invested Capital
-90.90%
N/A
Free Cash Flow
$9.83M
+42.6%
Operating Cash Flow
$9.83M
+42.6%